Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to $7.7 million.

  • Harmony Biosciences Holdings' Change in Receivables rose 56344.41% to $7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.1 million, marking a year-over-year increase of 3449.22%. This contributed to the annual value of $8.9 million for FY2024, which is 5415.98% down from last year.
  • Harmony Biosciences Holdings' Change in Receivables amounted to $7.7 million in Q3 2025, which was up 56344.41% from -$13.0 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Change in Receivables registered a high of $22.9 million during Q1 2025, and its lowest value of -$13.0 million during Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' median Change in Receivables value was $3.4 million (recorded in 2024), while the average stood at $4.1 million.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Change in Receivables skyrocketed by 221569.23% in 2023, and later tumbled by 47777.78% in 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Change in Receivables (Quarter) stood at $1.6 million in 2021, then crashed by 119.85% to -$325000.0 in 2022, then skyrocketed by 2215.69% to $6.9 million in 2023, then crashed by 77.73% to $1.5 million in 2024, then soared by 400.98% to $7.7 million in 2025.
  • Its Change in Receivables was $7.7 million in Q3 2025, compared to -$13.0 million in Q2 2025 and $22.9 million in Q1 2025.